Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma

NCT00378235 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped There was a change of sponsor. The new sponsor company did not wish to conduct the study after all.

Conditions

Interventions

Sponsor

INSYS Therapeutics Inc

Collaborators